Skip to content

Barry H Dash, Director at Elite Pharmaceuticals, bought ELTP on Aug 19, 2026

Prices as of Oct 1 · price update delayed · Every feed →

▲ BUY$8.6K30,000 shares at $0.29Barry H Dash DirectorELTP Elite Pharmaceuticals Inc
Watch ELTP
Traded
Aug 19, 2026
Disclosed
Sep 10, 2026
Filed
22 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Barry H Dash, Director at Elite Pharmaceuticals, bought ELTP on Aug 19, 2026TRADEDDISCLOSED
ELTPSimilar stocks (S&P 500 (SPY)), rebased to ELTP's price on the disclosure day
ELTP since disclosure
−9.6%
Similar stocks (SPY) since disclosure
+0.8%
S&P 500 (SPY)

Change in closing price from Sep 10, 2026 (the first trading day on or after disclosure) to Oct 1, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on ELTP →